Patents by Inventor Cynthia Lander

Cynthia Lander has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and Methods for Treating Cutaneous Scarring
    Publication number: 20140072613
    Abstract: The described invention provides compositions, dressings and methods for treating a cutaneous scar in a subject. The compositions of the derived invention contains a pharmaceutical composition comprising a therapeutic amount of a Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK2) inhibitor comprising an MK2 polypeptide inhibitor or a functional equivalent thereof, and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: March 14, 2013
    Publication date: March 13, 2014
    Inventors: Cynthia Lander, Caryn Peterson, Colleen Brophy
  • METHODS FOR TREATING OR PREVENTING VASCULAR GRAFT FAILURE
    Publication number: 20130115256
    Abstract: The described invention provides pharmaceutical compositions and methods for treating or preventing vascular graft failure in a subject in need of such treatment, the method comprising administering a therapeutically effective amount of a composition comprising a polypeptide of amino acid sequence YARAAARQARAKALARQLGVAA (SEQ ID NO: 1) or a functional equivalent thereof, and a pharmaceutically acceptable carrier. The methods also are clinically useful for treating a pre-atherosclerotic intimal hyperplasia condition.
    Type: Application
    Filed: May 24, 2011
    Publication date: May 9, 2013
    Inventors: Cynthia Lander, Alyssa Panitch, Colleen Brophy, Brandon Seal
  • Compositions And Methods For Preventing Or Treating Diseases, Conditions, Or Processes Characterized By Aberrant Fibroblast Proliferation And Extracellular Matrix Deposition
    Publication number: 20120263680
    Abstract: The described invention provides compositions and methods for preventing or treating a disease, condition, or pathologic process characterized by aberrant fibroblast proliferation and extracellular matrix deposition in a tissue of a subject. The method includes administering a therapeutic amount of a pharmaceutical composition comprising a polypeptide having the amino acid sequence YARAAARQARAKALARQLGVAA (SEQ ID NO: 1) or functional equivalent thereof, and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: April 12, 2012
    Publication date: October 18, 2012
    Applicant: MOERAE MATRIX, INC.
    Inventors: Cynthia Lander, Colleen Brophy
  • Methods for Treating or Preventing Vascular Graft Failure
    Publication number: 20110288036
    Abstract: The described invention provides pharmaceutical compositions and methods for treating or preventing vascular graft failure in a subject in need of such treatment, the method comprising administering a therapeutically effective amount of a composition comprising a polypeptide of amino acid sequence YARAAARQARAKALARQLGVAA (SEQ ID NO: 1) or a functional equivalent thereof, and a pharmaceutically acceptable carrier. The methods also are clinically useful for treating a pre-atherosclerotic intimal hyperplasia condition.
    Type: Application
    Filed: May 24, 2011
    Publication date: November 24, 2011
    Inventors: Cynthia Lander, Colleen Brophy, Brandon Seal